全文获取类型
| 收费全文 | 44901篇 |
| 免费 | 3343篇 |
| 国内免费 | 133篇 |
专业分类
| 耳鼻咽喉 | 667篇 |
| 儿科学 | 1144篇 |
| 妇产科学 | 693篇 |
| 基础医学 | 5846篇 |
| 口腔科学 | 1218篇 |
| 临床医学 | 4330篇 |
| 内科学 | 10391篇 |
| 皮肤病学 | 494篇 |
| 神经病学 | 4358篇 |
| 特种医学 | 1835篇 |
| 外科学 | 7184篇 |
| 综合类 | 368篇 |
| 一般理论 | 77篇 |
| 预防医学 | 3284篇 |
| 眼科学 | 657篇 |
| 药学 | 2639篇 |
| 中国医学 | 63篇 |
| 肿瘤学 | 3129篇 |
出版年
| 2023年 | 201篇 |
| 2022年 | 380篇 |
| 2021年 | 1048篇 |
| 2020年 | 633篇 |
| 2019年 | 1069篇 |
| 2018年 | 1305篇 |
| 2017年 | 922篇 |
| 2016年 | 1037篇 |
| 2015年 | 1168篇 |
| 2014年 | 1627篇 |
| 2013年 | 2019篇 |
| 2012年 | 3184篇 |
| 2011年 | 3208篇 |
| 2010年 | 1928篇 |
| 2009年 | 1574篇 |
| 2008年 | 2799篇 |
| 2007年 | 2974篇 |
| 2006年 | 2775篇 |
| 2005年 | 2755篇 |
| 2004年 | 2440篇 |
| 2003年 | 2310篇 |
| 2002年 | 2196篇 |
| 2001年 | 650篇 |
| 2000年 | 558篇 |
| 1999年 | 646篇 |
| 1998年 | 477篇 |
| 1997年 | 411篇 |
| 1996年 | 336篇 |
| 1995年 | 336篇 |
| 1994年 | 290篇 |
| 1993年 | 273篇 |
| 1992年 | 408篇 |
| 1991年 | 396篇 |
| 1990年 | 341篇 |
| 1989年 | 338篇 |
| 1988年 | 293篇 |
| 1987年 | 271篇 |
| 1986年 | 271篇 |
| 1985年 | 275篇 |
| 1984年 | 265篇 |
| 1983年 | 212篇 |
| 1982年 | 188篇 |
| 1981年 | 179篇 |
| 1980年 | 126篇 |
| 1979年 | 139篇 |
| 1978年 | 130篇 |
| 1977年 | 94篇 |
| 1976年 | 89篇 |
| 1973年 | 89篇 |
| 1972年 | 83篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
Deitelzweig Steve Luo Xuemei Nguyen Jennifer L. Malhotra Deepa Emir Birol Russ Cristina Li Xiaoyan Lee Theodore C. Ferri Mauricio Wiederkehr Danny Reimbaeva Maya Barnes Geoffrey D. Piazza Gregory 《Journal of thrombosis and thrombolysis》2022,54(4):696-696
Journal of Thrombosis and Thrombolysis - 相似文献
2.
3.
4.
5.
6.
Dan Azagury Tara E Mokhtari Luis Garcia Ulysses S Rosas Trit Garg Homero Rivas John Morton 《Surgery》2019,165(3):565-570
Background
Laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding all lead to substantial weight loss in obese patients. Long-term weight loss can be highly variable beyond 1-year postsurgery. This study examines and compares the frequency distribution of weight loss and lack of treatment effect rates after laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding.Methods
A total of 1,331 consecutive patients at a single academic institution were reviewed from a prospectively collected database. Preoperative data collected included demographics, body mass index, and percent excess weight loss. Postoperative BMI and %EWL were collected at 12, 24, and 36 months. Percent excess weight loss was analyzed by the percentiles of excess weight lost, and the distribution of percent excess weight loss was evaluated in 10% increments. Lack of a successful treatment effect was defined as <25% excess weight loss.Results
Of the 1,331 patients, 72.4% (963) underwent laparoscopic Roux-en-Y gastric bypass, 18.3% (243) laparoscopic sleeve gastrectomy, and 9.4%(125) laparoscopic adjustable gastric banding. Mean percent excess weight loss was greatest for laparoscopic Roux-en-Y gastric bypass, followed by laparoscopic sleeve gastrectomy, and then by laparoscopic adjustable gastric banding at every time point: at 2 years mean percent excess weight loss was 77.9± 24.4 for laparoscopic Roux-en-Y gastric bypass, 50.8 ± 25.8 for laparoscopic sleeve gastrectomy, and 40.8± 25.9 for laparoscopic adjustable gastric banding (P < .0001). The rates of a successful treatment effect s for laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding were 0.9%, 5.2%, and 24.3% at 1 year; 0.3%, 11.1%, and 26.0% at 2 years; and 1.0%, 25.3%, and 30.2% at 3 years. At 1 year, the odds ratio of lack of a successful treatment effect of laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass was 6.305 (2.125–19.08; P?=?.0004), the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass was 36.552 (15.64–95.71; P < .0001), and the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic sleeve gastrectomy was 5.791 (2.519–14.599; P < .0001). At 2 years, the odds ratio for laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass increased to 70.7 (9.4–531.7; P < .0001), the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass increased to 128.1 (16.8–974.3; P < .0001), and the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic sleeve gastrectomy decreased to 1.8 (0.9–3.6; P?=?.09).Conclusion
This study emphasizes the existing variability in weight loss across bariatric procedures as well as in the lack of a treatment effect for each procedure. Although laparoscopic adjustable gastric banding has the greatest rate of a lack of a successful treatment effect, the rate remained stable over 3 years postoperatively. Laparoscopic sleeve gastrectomy showed a doubling in the rate of a lack of a successful treatment effect every year reaching 25% at year 3. The rates for lack of a successful treatment effect for laparoscopic Roux-en-Y gastric bypass remained stable at about 1% for the first 3 years postoperatively. 相似文献7.
Andrea Stracciolini Jennifer Luz Gregory Walker Nicholas M. Edwards Avery D. Faigenbaum Gregory D. Myer 《The Physician and sportsmedicine》2020,48(2):199-207
ABSTRACT
Objective
To investigate primary care physician clinical practice patterns, barriers, and education surrounding pediatric physical activity (PA), and to compare practice patterns by discipline. 相似文献8.
9.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献